Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 94501-94550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04341701
Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases
NAActive, not recruiting
100 participants
Started: Aug 5, 2021 · Completed: Mar 30, 2024
1 condition1 sponsor6 locations
NCT04956692
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
PHASE3Active, not recruiting
531 participants
Started: Aug 5, 2021 · Completed: Oct 14, 2026
1 condition1 sponsor126 locations
NCT04713514
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
PHASE2Active, not recruiting
180 participants
Started: Aug 5, 2021 · Completed: Dec 31, 2025
2 conditions3 sponsors40 locations
NCT05484453
Validation of the GoCheck Kids® Eye Screeningtest in Infants in Flanders
N/AActive, not recruiting
460 participants
Started: Aug 4, 2021 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT04972851
AIRB-4: Self-Determined Learning Model of Instruction
NAActive, not recruiting
358 participants
Started: Aug 4, 2021 · Completed: Dec 1, 2025
2 conditions7 sponsors3 locations
NCT04997018
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer
PHASE2Recruiting
91 participants
Started: Aug 4, 2021 · Completed: Aug 4, 2026
1 condition1 sponsor7 locations
NCT04791839
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
30 participants
Started: Aug 4, 2021 · Completed: Dec 31, 2029
3 conditions2 sponsors1 location
NCT04921644
Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project)
N/AActive, not recruiting
1,183 participants
Started: Aug 4, 2021 · Completed: Dec 31, 2028
1 condition4 sponsors1 location
NCT04913727
Prediction of Reverse Remodeling and Outcome in Patients With Severe Secondary Mitral Valve Regurgitation Undergoing Transcatheter Edge-to-edge Mitral Valve Repair
NARecruiting
300 participants
Started: Aug 4, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05218889
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
PHASE1/PHASE2Recruiting
90 participants
Started: Aug 4, 2021 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT04998877
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
N/ARecruiting
60 participants
Started: Aug 4, 2021 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT04478578
Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
N/ARecruiting
100,000 participants
Started: Aug 4, 2021 · Completed: Dec 30, 2024
1 condition7 sponsors7 locations
NCT04640142
Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
PHASE3Active, not recruiting
50 participants
Started: Aug 4, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor24 locations
NCT04430569
Pulmonary Embolism International THrOmbolysis Study-3
PHASE3Recruiting
800 participants
Started: Aug 4, 2021 · Completed: Aug 31, 2028
1 condition7 sponsors98 locations
NCT04602377
Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT
PHASE2Recruiting
27 participants
Started: Aug 4, 2021 · Completed: Feb 28, 2030
1 condition2 sponsors12 locations
NCT04670510
Fitness for Brain Optimization for Late-Life Depression
NAActive, not recruiting
46 participants
Started: Aug 4, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04298203
Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity
PHASE2Active, not recruiting
100 participants
Started: Aug 4, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04913285
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
PHASE1Recruiting
400 participants
Started: Aug 4, 2021 · Completed: Mar 30, 2029
3 conditions1 sponsor36 locations
NCT04911920
Validation of a German Version of the Patient Rated Tennis Elbow Evaluation
NARecruiting
60 participants
Started: Aug 4, 2021 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT04996823
Axitinib + Ipilimumab in Advanced Melanoma
PHASE2Recruiting
25 participants
Started: Aug 4, 2021 · Completed: Mar 29, 2027
1 condition2 sponsors1 location
NCT04497584
Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
PHASE2Active, not recruiting
12 participants
Started: Aug 4, 2021 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT04899635
POWER Myocardial Fatigue Study: a Biomechanical Assessment of Contractility of Human Myocardium
N/ARecruiting
100 participants
Started: Aug 3, 2021 · Completed: Apr 30, 2025
4 conditions2 sponsors1 location
NCT05051722
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
N/ARecruiting
3,110 participants
Started: Aug 3, 2021 · Completed: Dec 30, 2026
6 conditions1 sponsor20 locations
NCT04971889
Diabetes Medical Nutrition Therapy in Southeastern African American Women
NARecruiting
291 participants
Started: Aug 3, 2021 · Completed: Jul 31, 2025
1 condition4 sponsors2 locations
NCT06350058
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
PHASE1Active, not recruiting
375 participants
Started: Aug 3, 2021 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT04399941
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
NARecruiting
50 participants
Started: Aug 3, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05658250
CREATE Trial, Prospective, Observational Study
N/ARecruiting
300 participants
Started: Aug 3, 2021 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT04348318
Advance Directive Implementation and Scientific Evaluation Study
N/ARecruiting
2,000 participants
Started: Aug 3, 2021 · Completed: Dec 31, 2050
1 condition1 sponsor2 locations
NCT04979429
The Perioperative Pain Self-Management Program Trial
NAActive, not recruiting
401 participants
Started: Aug 3, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT06767189
Preventing Recurrent Cardioembolic Stroke (The PRECISE Study)
N/AActive, not recruiting
675 participants
Started: Aug 3, 2021 · Completed: Aug 31, 2025
2 conditions2 sponsors3 locations
NCT04980066
Evaluation of Sticky Bone With or Without EDTA for Treatment of Gingival Recession
NARecruiting
20 participants
Started: Aug 3, 2021 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04626791
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
PHASE2Recruiting
45 participants
Started: Aug 3, 2021 · Completed: Aug 3, 2028
1 condition2 sponsors7 locations
NCT04969887
Combination Immunotherapy in Rare Cancers Under InvesTigation
PHASE2Active, not recruiting
240 participants
Started: Aug 3, 2021 · Completed: Mar 31, 2028
4 conditions2 sponsors18 locations
NCT04605731
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer
PHASE1Active, not recruiting
25 participants
Started: Aug 3, 2021 · Completed: Feb 25, 2026
10 conditions2 sponsors1 location
NCT04825366
Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training
NARecruiting
62 participants
Started: Aug 3, 2021 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05173298
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
N/ARecruiting
100 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04934293
Virtual Reality for Children in Radiotherapy (REVER)
NARecruiting
47 participants
Started: Aug 2, 2021 · Completed: Feb 28, 2027
3 conditions1 sponsor1 location
NCT06937788
Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
N/ARecruiting
240 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04974346
Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer
PHASE3Recruiting
455 participants
Started: Aug 2, 2021 · Completed: Aug 1, 2030
1 condition1 sponsor7 locations
NCT04790370
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
PHASE4Active, not recruiting
544 participants
Started: Aug 2, 2021 · Completed: Aug 31, 2026
1 condition3 sponsors63 locations
NCT03690011
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
PHASE1Recruiting
27 participants
Started: Aug 2, 2021 · Completed: May 1, 2040
3 conditions5 sponsors2 locations
NCT04936529
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
PHASE2Recruiting
286 participants
Started: Aug 2, 2021 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT06321822
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NARecruiting
500 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05117541
Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
N/AActive, not recruiting
365 participants
Started: Aug 2, 2021 · Completed: Mar 30, 2026
2 conditions2 sponsors1 location
NCT04608552
Effect of Myofunctional Therapy on OSA
NAActive, not recruiting
209 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04989335
Bisantrene Combination for Resistant AML
PHASE2Recruiting
29 participants
Started: Aug 2, 2021 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT04761328
Fear of Recurrence and Stopping Immunotherapy
NARecruiting
100 participants
Started: Aug 2, 2021 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04560335
Coach to Fit Weight Loss Intervention for Individuals With Serious Mental Illness
NAActive, not recruiting
257 participants
Started: Aug 2, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT04977453
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
430 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2026
14 conditions2 sponsors8 locations
NCT04107636
Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance
NARecruiting
170 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors1 location